Latest News and Press Releases
Want to stay updated on the latest news?
-
ANN ARBOR, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026
-
EyeMD EMR Healthcare Systems Announces Rebrand to Optivate, Signaling Expanded Vision for Ophthalmology Practices and Eye Care Providers
-
BVI Medical, announced that it has received 510(k) clearance from the U.S. FDA for its innovative glaucoma surgical system, Leos™
-
RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers
-
RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes
-
The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event.
-
Austin, TX, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative...
-
OK-101 is the first drug candidate to enroll patients specifically diagnosed with Neuropathic Corneal Pain (NCP) in a clinical trialThe Phase 2 trial is designed as a randomized, placebo-controlled,...
-
Austin, TX, USA, June 24, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cosmetic Pigments Market Size, Trends and Insights By Type (Surface Treated...